Chris is currently the Commercial Director at Intertek Pharmaceutical Services, where his responsibilities include leading the business development team at their inhaled and nasal drug product centre of excellence near Cambridge, UK, and establishing partnerships and collaborations across the respiratory industry.

Chris is a Chemist by training, and holds a master’s degree in Medicinal and Pharmaceutical Chemistry from Loughborough University. He started his career at Nanopharm in 2010, as an Inhalation Scientist, working on formulation development and analytical testing projects, before moving to Intertek in 2013, as a Senior Scientist.

Chris progressed into a business development role at Intertek in 2014 and has also worked in commercial roles at Aptar Pharma and Vectura, before re-joining Intertek in 2022 in his current position. Chris is incredibly passionate about respiratory drug product development and regularly advises companies on technical and commercial strategy for their programs.